Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival
出版年份 2020 全文链接
标题
Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival
作者
关键词
-
出版物
Frontiers in Immunology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-09-15
DOI
10.3389/fimmu.2020.01933
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
- (2019) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Comprehensive Genomic Profiling Identifies Novel Genetic Predictors of Response to Anti-PD-(L)1 Therapies in Non-Small-Cell Lung Cancer
- (2019) Wenfeng Fang et al. CLINICAL CANCER RESEARCH
- OA04.05 KEYNOTE-021: TMB and Outcomes for Carboplatin and Pemetrexed With or Without Pembrolizumab for Nonsquamous NSCLC
- (2019) C. Langer et al. Journal of Thoracic Oncology
- Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer
- (2018) Mark A. Socinski et al. Journal of Thoracic Oncology
- Integrated genomic analyses of lung squamous cell carcinoma for identification of a possible competitive endogenous RNA network by means of TCGA datasets
- (2018) Pengbo Ning et al. PeerJ
- Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors
- (2018) Aaron M. Goodman et al. JAMA Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification of SPP1 as a promising biomarker to predict clinical outcome of lung adenocarcinoma individuals
- (2018) Shicheng Li et al. GENE
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- A molecular and staging model predicts survival in patients with resected non-small cell lung cancer
- (2018) Lei Liu et al. BMC CANCER
- Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma
- (2018) Chundi Gao et al. Cancer Cell International
- Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism
- (2018) Jingjing Zhu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Maftools: efficient and comprehensive analysis of somatic variants in cancer
- (2018) Anand Mayakonda et al. GENOME RESEARCH
- Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis
- (2018) Cheng Xu et al. BMJ-British Medical Journal
- Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
- (2017) Jacob Schachter et al. LANCET
- Integrative clinical genomics of metastatic cancer
- (2017) Dan R. Robinson et al. NATURE
- PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1
- (2016) Alexandra Lacey et al. CANCER RESEARCH
- High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome
- (2016) Evan Delgado et al. GYNECOLOGIC ONCOLOGY
- Predictive biomarkers for checkpoint inhibitor-based immunotherapy
- (2016) Geoffrey T Gibney et al. LANCET ONCOLOGY
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-small-cell lung cancer
- (2015) Cesare Gridelli et al. Nature Reviews Disease Primers
- ImmPort: disseminating data to the public for the future of immunology
- (2014) Sanchita Bhattacharya et al. IMMUNOLOGIC RESEARCH
- First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
- (2014) Benjamin J. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Net time-dependent ROC curves: a solution for evaluating the accuracy of a marker to predict disease-related mortality
- (2014) Marine Lorent et al. STATISTICS IN MEDICINE
- Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling
- (2014) FangFang Zhou et al. Nature Communications
- Neuropilin 1 guides regulatory T cells into VEGF-producing melanoma
- (2013) Wiebke Hansen OncoImmunology
- Weeklynab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
- (2012) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status
- (2012) She-Juan An et al. PLoS One
- Targeting NR4A1 (TR3) in cancer cells and tumors
- (2011) Syng-Ook Lee et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Comparison of lung cancer cell lines representing four histopathological subtypes with gene expression profiling using quantitative real-time PCR
- (2010) Takashi Watanabe et al. Cancer Cell International
- Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
- (2010) Makoto Maemondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies
- (2009) G. Scagliotti et al. ONCOLOGIST
- Leptin Receptor-Related Immune Response in Colorectal Tumors: The Role of Colonocytes and Interleukin-8
- (2008) M. Abolhassani et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search